🔎 Trials Near Me

Home › Non-Small Cell Lung Cancer › Pennsylvania › Chambersburg

Non-Small Cell Lung Cancer clinical trials in Chambersburg, PA

6 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Chambersburg (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

RecruitingPhase 3
  • WellSpan Medical Oncology and Hematology, Chambersburg
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT04267848

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

RecruitingPhase 2
  • WellSpan Medical Oncology and Hematology, Chambersburg
Ages 18 and older · All sexes · Updated Jun 3, 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

RecruitingPhase 2
  • WellSpan Medical Oncology and Hematology, Chambersburg
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT06116682

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

RecruitingPhase 2
  • WellSpan Medical Oncology and Hematology, Chambersburg
18 Minutes · All sexes · Updated May 5, 2026 · NCT06031688

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

RecruitingObservational study
  • WellSpan Medical Oncology and Hematology, Chambersburg
Ages 18 and older · All sexes · Updated Mar 17, 2026 · NCT06418204

Non-Small Cell Lung Cancer trials in other cities

Other studies in Chambersburg

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.